You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

698 Results
Drug
Other Name(s): Matulane®
Dec 2019
Drug
Other Name(s): Tomudex®
Sep 2024
Drug
Other Name(s): Stivarga®
Nov 2023
Drug
Other Name(s): Perjeta®
Sep 2022
Drug
Other Name(s): Istodax®
Mar 2023
Drug
Other Name(s): Cyramza®
Mar 2023
Drug
Other Name(s): Iclusig®
Aug 2023
Drug
Other Name(s): Ibrance™
May 2021
Regimen
Cancer Type:
Central Nervous System
Intent: Adjuvant, Curative, Palliative
Funding:
ODB - General Benefit
    procarbazine
ODB - General Benefit
    lomustine
Jan 2023
Regimen
Regimen
Cancer Type:
Gynecologic, 
Ovary
Intent: Palliative
Nov 2024
Regimen
Cancer Type:
Sarcoma, 
Kaposi's Sarcoma
Intent: Palliative
Nov 2024

Pages